← Back to Search

Behavioral Intervention

Decision Aid for Breast Cancer Screening

N/A
Recruiting
Led By Christine M Gunn, PhD
Research Sponsored by Trustees of Dartmouth College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No personal history of breast cancer
Females aged 40-49
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately pre-intervention, within 1 day post-intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test an online tool that helps women make decisions about breast cancer screening. The study will focus on women living in an area with increased environmental pollution and aims to understand how their experiences and

Who is the study for?
This trial is for women aged 40-49 who live in Hillsborough County, NH, have not had a mammogram in the past year, and have never been diagnosed with breast cancer. Participants must have resided in the area since at least 2018.
What is being tested?
The study is testing an online tool called MyMammogram decision aid. It's designed to help women make informed choices about breast cancer screening, especially those living in areas affected by environmental contamination.
What are the potential side effects?
Since this trial involves an informational decision aid rather than a medical treatment or drug, there are no direct physical side effects associated with participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have never had breast cancer.
Select...
I am a woman aged between 40 and 49.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately pre-intervention, within 1 day post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately pre-intervention, within 1 day post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability
Secondary study objectives
Decisional Conflict
Knowledge
Screening Intentions
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Decision AidExperimental Treatment1 Intervention
Participants will receive the adapted MyMammogram decision aid that includes environmental risk information.

Find a Location

Who is running the clinical trial?

Trustees of Dartmouth CollegeLead Sponsor
27 Previous Clinical Trials
11,114 Total Patients Enrolled
Dartmouth-Hitchcock Medical CenterLead Sponsor
537 Previous Clinical Trials
2,539,652 Total Patients Enrolled
Christine M Gunn, PhDPrincipal InvestigatorDartmouth College, Geisel School of Medicine
~67 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top